Lexaria Bioscience (LEXX) Total Debt Growth (3y) (2018 - 2022)
Lexaria Bioscience (LEXX) Total Debt Growth (3y) (2018 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.63 Mn |
2.11 Mn |
20,000.00 |
- |
| Date | Value |
|---|
| May 31, 2022 |
-27.79% |
| Nov 30, 2021 |
-28.80% |
| Aug 31, 2021 |
0.30% |
| May 31, 2021 |
-47.42% |
| Feb 28, 2021 |
233.13% |
| Nov 30, 2020 |
67.72% |
| Aug 31, 2020 |
-10.44% |
| May 31, 2020 |
98.63% |
| Feb 29, 2020 |
-82.18% |
| Nov 30, 2019 |
-53.65% |
| Aug 31, 2019 |
-47.45% |
| May 31, 2019 |
-56.60% |
| Feb 28, 2019 |
-71.32% |
| Nov 30, 2018 |
-41.41% |
| Aug 31, 2018 |
-29.11% |
| Feb 28, 2018 |
46.78% |
